Event - 17/09/2026 - 18/09/2026 Translational Protein Biomarker Workshop Reutlingen, Informationsveranstaltung https://www.gesundheitsindustrie-bw.de/en/event/translational-protein-biomarker-workshop
Funding Continuous Hormone Monitoring Funding programme, Funded by: SPRIN-D, sb_search.searchresult.label.programSubmissionDate: 26/06/2026 https://www.gesundheitsindustrie-bw.de/en/database/funding/continuous-hormone-monitoring
Funding Funke Quantum-Driven Intelligence Funding programme, Funded by: SPRIN-D, sb_search.searchresult.label.programSubmissionDate: 06/09/2026 https://www.gesundheitsindustrie-bw.de/en/database/funding/funke-quantum-driven-intelligence
Funding Funke QuantumSense Exploration Funding programme, Funded by: SPRIN-D, sb_search.searchresult.label.programSubmissionDate: 06/09/2026 https://www.gesundheitsindustrie-bw.de/en/database/funding/funke-quantumsense-exploration
Cancer prevention with a single jab - 20/05/2026 Therapeutic vaccine against HPV-induced tumours Persistent infections with human papillomaviruses (HPV) are the primary cause of cervical cancer. Researchers from Heidelberg have developed a promising therapeutic vaccine consisting of immunogenic virus peptides linked to silica nanoparticles, which is currently being investigated in preclinical studies. The vaccine activates specific cytotoxic T cells and is usable regardless of HLA type.https://www.gesundheitsindustrie-bw.de/en/article/news/therapeutic-vaccine-against-hpv-induced-tumours
Press release - 18/05/2026 Gene scissors show promise for treating a rare immune disorder Medical Center – University of Freiburg demonstrates a fundamental therapeutic approach for hereditary immune system defects in a mouse model. The safety profile of genome editing varies significantly depending on the method and cell type.https://www.gesundheitsindustrie-bw.de/en/article/press-release/gene-scissors-show-promise-treating-rare-immune-disorder
Press release - 15/05/2026 Heidelberg Collaborative Research Centre “Molecular Circuits of Heart Disease” secures second funding period The Collaborative Research Centre (CRC) 1550 “Molecular Circuits of Heart Disease” at Heidelberg University is entering its second funding period. The German Research Foundation (DFG) has approved approximately EUR 17.4 million in funding for the next four years. The spokesperson is Johannes Backs, Professor of Experimental Cardiology at the Heidelberg Faculty of Medicine.https://www.gesundheitsindustrie-bw.de/en/article/press-release/heidelberg-collaborative-research-centre-molecular-circuits-heart-disease-secures-second-funding-period
Press release - 15/05/2026 Neuroendocrine Tumors: Freiburg Becomes a European Center of Excellence The Medical Center – University of Freiburg has been certified for the first time as a “Center of Excellence” by the European Neuroendocrine Tumor Society (ENETS). The professional association recognizes specialized centers that treat rare tumor diseases in accordance with established quality standards. Neuroendocrine tumors are rare cancers that can arise from hormone-producing cells. https://www.gesundheitsindustrie-bw.de/en/article/press-release/neuroendocrine-tumors-freiburg-becomes-european-center-excellence
Press release - 13/05/2026 “AI doesn't really have a clue what it's doing” AI is transforming science and does not stop at neuroscience. In this interview, we speak to Gabriele Lohmann about her research at the intersection of the brain and algorithms. She talks about the use of artificial intelligence as a research tool, the decoding of brain activity, and why large language models do not understand what they are doing.https://www.gesundheitsindustrie-bw.de/en/article/press-release/ai-doesnt-really-have-clue-what-its-doing
Press release - 13/05/2026 NVision Expands from Quantum Sensing to Quantum Computing to Accelerate Discovery and Validation of New Therapies NVision announced a $55 million Series B led by Abbott and unveiled PIQC, a new quantum computing platform built on its molecular quantum technology.https://www.gesundheitsindustrie-bw.de/en/article/press-release/nvision-expands-quantum-sensing-quantum-computing-accelerate-discovery-and-validation-new-therapies-en
Funding GRIOS call for evidence synthesis 2026 Funding programme, Funded by: European Science Foundation (ESF), sb_search.searchresult.label.programSubmissionDate: 20/07/2026 https://www.gesundheitsindustrie-bw.de/en/database/funding/grios-call-evidence-synthesis-2026
Press release - 12/05/2026 3D Microscopy: Laser Rotates Samples Contact-Free Until now, it has been technically nearly impossible to rotate highly sensitive samples in all directions under a microscope without making contact. Researchers at the KIT have developed a new laser-based technique that allows microscopic samples such as cells to be rotated contact-free in all three spatial directions. The laser creates tiny temperature differences in the liquid, which trigger gentle fluid flows that move the sample. https://www.gesundheitsindustrie-bw.de/en/article/press-release/3d-microscopy-laser-rotates-samples-contact-free
Press release - 12/05/2026 The Silent Killer: Early Detection and Targeted Treatment of High Blood Pressure High blood pressure is one of the most common causes of heart attacks, strokes, kidney damage, and vascular diseases. Many people affected experience no symptoms for a long time. This is precisely why it is important to check your blood pressure regularly. To mark World Hypertension Day on May 17, the Medical Center – University of Freiburg is providing information on warning signs, diagnosis, and treatment options.https://www.gesundheitsindustrie-bw.de/en/article/press-release/silent-killer-early-detection-and-targeted-treatment-high-blood-pressure
Press release - 12/05/2026 University of Stuttgart joins the European University Alliance EULiST The University of Stuttgart has become a new Cooperation Partner of the European University Alliance EULiST. By signing the cooperation agreement in Lappeenranta, Finland, the university is further expanding its European network and contributing its expertise at the intersection of technology, science, and society to the alliance.https://www.gesundheitsindustrie-bw.de/en/article/press-release/university-stuttgart-joins-european-university-alliance-eulist
Press release - 11/05/2026 Alexander von Humboldt professorship for Simon Elsässer – “You can think of it as a kind of cellular memory” Prof. Dr Simon Elsässer will be awarded one of this year’s Alexander von Humboldt Professorships in Berlin on 12 May 2026. With funding of five million euros, Elsässer will strengthen Freiburg’s research focus ‘Signals of Life’ over the next five years. In this interview, he discusses complex decision-making processes in cells, the significance of signals and what makes the research environment in Freiburg so special.https://www.gesundheitsindustrie-bw.de/en/article/press-release/alexander-von-humboldt-professorship-simon-elsasser-you-can-think-it-kind-cellular-memory
Press release - 11/05/2026 Radar warns of a risk of falling at the hospital The Medical Center – University of Freiburg has implemented a new system that helps nurses identify risky situations early on and provide more targeted assistance / Motion detection is performed using radarhttps://www.gesundheitsindustrie-bw.de/en/article/press-release/radar-warns-risk-falling-hospital
Press release - 11/05/2026 Elke Deuerling elected as Leopoldina member Konstanz molecular biologist Elke Deuerling has been admitted to the German National Academy of Sciences, the "Leopoldina". By selecting Elke Deuerling as a member, the Academy recognizes her outstanding contributions to the field of life sciences, particularly to proteostasis research.https://www.gesundheitsindustrie-bw.de/en/article/press-release/elke-deuerling-elected-leopoldina-member
Press release - 11/05/2026 What Really Helps People Quit Smoking Whether people try to quit smoking depends heavily on public health policies in their respective countries – whether they are successful, however, depends primarily on their personal environment and behavior. This was the finding of researchers from the German Cancer Research Center (DKFZ) in an international study.https://www.gesundheitsindustrie-bw.de/en/article/press-release/what-really-helps-people-quit-smoking
Press release - 08/05/2026 The Plasticity of Malignant Brain Tumors as a Potential Therapeutic Approach: Sibylle Assmus Prize for Neuro-Oncology Awarded to Moritz Mall The ability of cancer cells to change their identity makes tumors such as glioblastoma particularly aggressive and resistant to treatment. Moritz Mall, of the German Cancer Research Center (DKFZ) and the Hector Institute for Translational Brain Research (HITBR), is investigating how this plasticity can be specifically restricted. His approach focuses on genetic “guardians” that suppress alternative cell programs. https://www.gesundheitsindustrie-bw.de/en/article/press-release/plasticity-malignant-brain-tumors-potential-therapeutic-approach-sibylle-assmus-prize-neuro-oncology-awarded-moritz-mall
Press release - 07/05/2026 Cooperative project researches interaction of top female athletes’ menstrual cycle, performance and health The Athletin-D project combines the universities of Bochum, Freiburg, Wuppertal and the Technical University of Munich on research into how the performance and health of female athletes could be improved in Olympic and paralympic sports. At the University of Freiburg, the sports psychologist Professor Jana Strahler is studying the interaction of hormonal processes, stress, lifestyle factors and mental health.https://www.gesundheitsindustrie-bw.de/en/article/press-release/cooperative-project-researches-interaction-top-female-athletes-menstrual-cycle-performance-and-health
Press release - 07/05/2026 Leukemia stem cells cause treatments to fail - Findings open new avenues to overcome resistance Scientists from the German Cancer Research Center (DKFZ) and the HI-STEM* Stem Cell Institute have deciphered a key mechanism that contributes to treatment failure in acute myeloid leukemia (AML). They show that there are not just one, but four different subtypes of leukemia stem cells. This diversity could explain why one of the most important AML drugs does not work sufficiently in some patients or loses its effectiveness over time.https://www.gesundheitsindustrie-bw.de/en/article/press-release/leukemia-stem-cells-cause-treatments-fail-findings-open-new-avenues-overcome-resistance
Press release - 07/05/2026 MRI is a better indicator than BMI of when body fat becomes dangerous MRI analysis of fat and muscle distribution in more than 66,000 people provides a more accurate assessment of health risks / Poor muscle quality poses an additional risk / Study provides reference values based on age, sex, and heighthttps://www.gesundheitsindustrie-bw.de/en/article/press-release/mri-better-indicator-bmi-when-body-fat-becomes-dangerous
Press release - 06/05/2026 International Symposium "Frontiers in Skin Immunity" brings leading immunologists to Heidelberg From May 15–16, 2026, the 3rd International Symposium “Frontiers in Skin Immunity” will bring leading experts in dermatology and immunology to Heidelberg. Organized by the SFB Transregio 156 “The Skin as Sensor and Initiator of Local and Systemic Immunity” and the Medical Faculty of Heidelberg University the meeting highlights advances in understanding skin immune responses and marks the conclusion of the consortium’s third funding period. https://www.gesundheitsindustrie-bw.de/en/article/press-release/international-symposium-frontiers-skin-immunity-brings-leading-immunologists-heidelberg
Press release - 04/05/2026 Recommendation for Better Protection: Outdoor Workers Particularly Vulnerable to Melanoma, Study Finds As the sun rises higher in the sky this spring, UV exposure increases. This should be addressed with proper sun protection. New data shows that people who work outdoors frequently are at a significantly higher risk of developing melanoma on their faces. At the same time, many affected individuals lack awareness of the risks and fail to use systematic sun protection. https://www.gesundheitsindustrie-bw.de/en/article/press-release/recommendation-better-protection-outdoor-workers-particularly-vulnerable-melanoma-study-finds
Press release - 04/05/2026 How personalised is healthcare? This year’s Health Congress at Furtwangen University (HFU) focused on the timely topic of personalised healthcare. With the theme “Health for EVERYONE! – Successful Strategies Through personalised Healthcare,” HFU hosted the event for the 15th time in collaboration with the Black Forest-Baar Health Network, the Furtwangen University Support Association PRO HFU e.V., and the City of Furtwangen.https://www.gesundheitsindustrie-bw.de/en/article/press-release/how-personalised-healthcare